Robert Lin
Ophthalmology · City Of Industry, CANPI 1760456248
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Carl Zeiss Meditec, Inc. accounts for 85.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $31,033 and has fallen 89.8% since, to $3,152 in 2025. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $460.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$68K
- Carl Zeiss Meditec USA, Inc.$8K
- Bausch & Lomb Americas Inc.$904
- Shire North American Group Inc$377
- Alcon$373
- Sun Pharmaceutical Industries Inc.$282
- plus $972 from 15 others
Across 1 payment — averaging $6000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Carl Zeiss Meditec, Inc.$6K
What the payments were for
- Consulting fees$38,58349%
- Speaking & faculty fees$8,67011%
- Travel & lodging$19,80425%
- Food & beverage$6,5148%
- Education$50%
- Gifts$2700%
- Other$5,3947%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 78 | $68,028 |
| Carl Zeiss Meditec USA, Inc. | 29 | $8,302 |
| Bausch & Lomb Americas Inc. | 9 | $904 |
| Shire North American Group Inc | 11 | $377 |
| Alcon | 6 | $373 |
| Sun Pharmaceutical Industries Inc. | 13 | $282 |
| Oyster Point Pharma, Inc. | 5 | $223 |
| Dompe US, Inc. | 2 | $159 |
| Biotissue Holdings Inc. | 2 | $141 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $116 |
| Rxsight Inc | 3 | $57 |
| Novartis | 2 | $43 |
| AbbVie | 2 | $40 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $35 |
| Exelixis Inc. | 1 | $24 |
| Staar Surgical Company | 1 | $22 |
| Beaver-visitec International, Inc. | 1 | $21 |
| Sight Sciences, Inc. | 1 | $20 |
| Kaleo, Inc. | 1 | $17 |
| Harrow Eye, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VisuMax$49,759
- VERACITY SURGICAL$15,273
- CIRRUS HD-OCT$12,883
- Retina Workplace$12,883
- ARTEVO 800$9,900
- LUMERA 700$5,394
- QUATERA 700$2,275
- AT LISA$1,560
- CT Lucia$1,560
- IOLMaster$1,560
- enVista MX60 IOL$701
- AMVISC$596
- XIIDRA$232
- SOFPORT AO$211
- Clareon$150
- TRYPTYR$144
- TYRVAYA$143
- Oxervate$125
- Tecnis IOL$116
- CALLISTO eye$114
How this compares
$79,239 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in City Of Industry
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
- Andrew MoshfeghiLos Angeles$895K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.